Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival

01/08/2022

Matteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, Halima Abahssain, Gaetano Aurilio, Javier Molina-Cerrillo, Zin W Myint, Ignacio Ortego Zabalza, Nicola Battelli, Enrique Grande

DOI: 10.1016/j.critrevonc.2022.103731

Full link: https://www.sciencedirect.com/science/article/abs/pii/S104084282200155X?via%3Dihub

Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival

Send us a message

Cura Project

Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival

Related Posts

In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”

Moderately hypofractionated post-operative radiation therapy for breast cancer: Preferences amongst radiation oncologists from countries in Latin America and the Caribbean

TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018

Subgroup analysis of Brazilian participants of a medical leadership competencies instrument: a cross-sectional survey study of the Latin American Cooperative Oncology Group (LACOG) and the Academy of Leadership Sciences Switzerland (ALSS)